A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

Abstract

BackgroundA simple, rapid and accurate stability-indicating reverse phase high performance liquid chromatography (RP-HPLC) was developed and validated for the determination of brimonidine tartrate in brimonidine tartrate/poly(2-hydroxyethyl methacrylate) (BRI/PHEMA) drug delivery contact lenses and pharmaceutical formulations.ResultsOptimum chromatographic conditions for separating brimonidine tartrate from other impurities in the leaching liquor of BRI/PHEMA drug delivery contact lenses or pharmaceutical formulations have been achieved by using a Diamonsil C18 column (150 mm × 4.6 mm, 5 μm) as a stationary phase and a mixture solution of phosphate buffer (10 mM, pH3.5) containing 0.5% triethlamine and methanol (85:15, v/v) as a mobile phase at a flow rate of 1 mL/min. The theoretical plates for the brimonidine tartrate measurement were calculated to be 8360 when detection was performed at 246 nm using a diode array detector. The proposed method was validated in accordance with ICH guidelines with respect to linearity, accuracy, precision, robustness, specificity, limit of detection and quantitation. Regression analysis showed a good correlation (R2 > 0.999) for brimonidine tartrate in the concentration range of 0.01–50 μg/mL. The peak purity factor is ≥980 for the analyte after all types of stress tests, indicating an excellent separation of brimonidine tartrate peak from other impurities. The measurement course could be completed within 10 min, which was very quick, effective and convenient.ConclusionsOverall, the proposed stability-indicating method was suitable for routine quality control and drug analysis of brimonidine tartrate in BRI/PHEMA drug delivery contact lenses and other pharmaceutical formulations.

Sustained release of brimonidine from polydimethylsiloxane-coating silicone rubber implant to reduce intraocular pressure in glaucoma

“…After the administration of BRI@SR@PDMS implant or BRI eye drops (0.15%) to rabbit eyes ( n = 5), 100 μl of aqueous humor was extracted with a 1-ml syringe at 1, 6, 24, 48, 96 and 192 h. All aqueous humor samples were stored at −80°C before the analysis with liquid chromatography-mass spectrometry system as previous described [ 42 ].…”

Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

“…The quantification of brimonidine was performed using a previously described method with some modifications [ 33 ]. Tracer excell 120 ODSA 5 µm 15 × 0.4 TR-015694 column was employed (Teknocroma).…”

Development of a stability indicating high-performance liquid chromatography method for determination of cenobamate: study of basic degradation kinetics

“…The mechanism of action for CNB is still unclear, however some studies suggest that CNB can inhibit sodium channels resulting in based on the chemical characteristics of the active pharmaceutical ingredients (API), product type, and storage requirements, aiming for a degradation range of 5 to 20%, as exceeding this range would be unrealistic [12]. Forced degradation studies are important as they provide information about stability of pharmaceutical products in different environmental conditions such as relative humidity, light, and temperature and they help in identifying potential degradation pathways and impurity profiling [13,14]. The study of degradation kinetics are also essential for establishing the optimal storage conditions and predicting the shelf life of drug substances under different environmental conditions.…”